The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations
Abstract Background Metabolic dysfunction-associated fatty liver disease (MAFLD) has been proposed as a new term for diagnosing fatty liver disease, which is considered to be a multi-systemic disease with multiple extrahepatic manifestations, including sarcopenia. The link between sarcopenia and MAF...
Main Authors: | Ziyan Feng, Fanrong Zhao, Ziyao Wang, Xinyi Tang, Yan Xie, Li Qiu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-024-03192-0 |
Similar Items
-
Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease
by: Ho Soo Chun, et al.
Published: (2021-10-01) -
Implications of Protein and Sarcopenia in the Prognosis, Treatment, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
by: Avneet Singh, et al.
Published: (2024-02-01) -
Sarcopenia Imperils Postoperative Long-Term Survival in HCC Patients with Metabolic Dysfunction-Associated Fatty Liver Disease: A Propensity Score Matching Analysis
by: Kong Q, et al.
Published: (2023-08-01) -
Impact of anthropometric parameters on outcomes in Asians with metabolic dysfunction‐associated fatty liver disease
by: Kyu Yeon Choi, et al.
Published: (2023-12-01) -
Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease
by: Michihiro Iwaki, et al.
Published: (2023-02-01)